The initiative is aimed at combating fraud and will kick in at the start of next year.Policy, news, Indonesia, Regulation, SandboxesRead More

You might also be interested in reading Arcturus outlines pivotal trial plans and advances CF and OTC programs with regulatory meetings expected in 2026.